AXIM BIOTECHNOLOGIES, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

AXIM BIOTECHNOLOGIES, INC. reported Cash And Cash Equivalents At Carrying Value of $47.3 thousand for the year ending 2022.

  • AXIM BIOTECHNOLOGIES, INC. showed a decrease of -89.6% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from AXIM BIOTECHNOLOGIES, INC.'s annual report (Form 10-K), filed with the SEC on April 17, 2023.
  • XBRL data for this metric is available from 2010 to 2022 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2022: $47.3 thousand | Fiscal year 2021: $453.0 thousand | Fiscal year 2018: $1.81 million | Fiscal year 2017: $2.06 million | Fiscal year 2016: $713.3 thousand | Fiscal year 2015: $134.2 thousand | Fiscal year 2014: $661.1 thousand | Fiscal year 2013: $127.00 | Fiscal year 2012: $19.1 thousand | Fiscal year 2011: $23.1 thousand | Fiscal year 2010: $0.00 | Fiscal year 2010: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: